Home
About DL
Company Profile
Corporate culture
Qualifications and Honors
Product Solution
Clinical Microbiological Diagnosis
Industrial Microbial Testing
User Services
News Updates
DL Information
Contact DL
MALDI‑TOF MS Search
Exhibition Activities
Interpretation of the “Notice from the General Office of the National Health Commission on Continuously Strengthening the Management of Clinical Use of Antimicrobial Agents”
In order to thoroughly implement the Outline of the “Healthy China 2030” Plan and the National Action Plan on Controlling Bacterial Resistance (2016–2020), and to continuously strengthen the management of clinical antimicrobial use, ensure medical quality, and curb bacterial resistance, the National Health Commission has issued the “Notice on Continuously Strengthening Relevant Work in the Clinical Management of Antimicrobial Agents” (hereinafter referred to as the “Notice”).
12
2019
/
04
Notice from the General Office of the National Health Commission on Continuously Strengthening the Management of Clinical Use of Antimicrobial Agents
To thoroughly implement the “Healthy China 2030” Planning Outline and the National Action Plan to Contain Bacterial Resistance (2016–2020), further strengthen the management of clinical antimicrobial use, ensure medical quality, and curb bacterial resistance, the following work requirements are hereby put forward.
[Invitation] Deer Biotech invites you to attend the 81st CMEF Expo!
Dear Sir/Madam, The 81st China International Medical Equipment Fair (Spring) will be held from May 14 to 17, 2019, at the National Exhibition and Convention Center in Shanghai. As a leading domestic supplier of microbiological diagnostic products, Zhuhai Dier Bioengineering Co., Ltd. will showcase its latest innovations in the IVD Pavilion, booth number 3G06. With deep expertise in the microbiological diagnostics field, Dier Bio has developed eight major categories of automated microbial diagnostic instruments and in vitro diagnostic reagents, offering comprehensive solutions for the clinical identification of pathogenic microorganisms. We warmly welcome experts and colleagues to visit our booth for guidance and discussion. — Zhuhai Dier Bioengineering Co., Ltd. CMEF 2019
30
2019 Spring CMEF: Dier Bio – A Highlight Reel
On May 17, 2019, the four-day 81st China International Medical Equipment Fair (CMEF) successfully concluded at the Shanghai National Exhibition and Convention Center. With the theme “Intelligence Reimagines the Future,” the IVD in‑vitro diagnostics zone— a key exhibition area of CMEF—was primarily located in Hall 3, drawing enthusiastic crowds and a steady stream of visitors. At booth 3G06, Dier Biotech showcased its independently developed automated clinical diagnostic instruments and diagnostic reagents, presenting a comprehensive microbial diagnostics solution to attendees. Quality that conquers the world: As a leading national brand in the field of microbial diagnostics, Dier Biotech…
17
05
Exhibition News | Dier Biotech Supports New Advances in Clinical Diagnostic Technologies for Women and Children in China
Conference Summary: From May 24 to 26, 2019, the Third China Conference on Clinical Diagnosis and Laboratory Medicine for Women and Children, hosted by the China Maternal and Child Health Association, successfully concluded in Nanchang, Jiangxi Province. The conference theme was “Standardization and Popularization, Innovation and Advancement,” with presentations focusing on cutting-edge diagnostic technologies and consensus guidelines for the three-tier prevention and control of birth defects, as well as for common gynecological and pediatric conditions. Conference Presentations: Zhuhai Dier Bioengineering Co., Ltd. showcased its independently developed Streptococcus Group B culture and analysis system at the event and delivered a presentation titled “Clinical Application of Prenatal Screening for Streptococcus Group B” at the Clinical Laboratory Forum.
28
Dil Bio Supports the Rational Use of Antibiotics—The 16th National Conference on Clinical Pharmacology of Anti-Infective Drugs and the 4th National Symposium on Bacterial Resistance Surveillance Conclude Successfully
Exhibition Information
02
07